Clinical Trial Update: Clinical Study of Allogeneic Fat Decellularized Active Protein in the Treatment of Pulmonary Fibrosis [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 clinical study of allogeneic fat decellularized active protein for pulmonary fibrosis is listed as active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Fibrosis

Drugs mentioned

• Allogeneic Fat Decellularized Active Protein

Snippet

Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | Conditions: Pulmonary Fibrosis | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING